Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents SCORE2 report 12: secondary analysis of the SCORE2 clinical trial
作者单位:Northern Calif Retina Vitreous Assoc, Mountain View, CA USA[1]Univ Wisconsin, Fundus Photograph Reading Ctr, Madison, WI USA[2]Emmes Co LLC, 401 N Washington St,Suite 700, Rockville, MD 20850 USA[3]Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA USA[4]Penn State Coll Med, Dept Ophthalmol, Hershey, PA USA[5]